ACM

Aisling Capital Management Portfolio holdings

AUM $360M
This Quarter Return
+47.75%
1 Year Return
+114.67%
3 Year Return
+1,171.46%
5 Year Return
+892.24%
10 Year Return
–
AUM
$131M
AUM Growth
+$131M
Cap. Flow
+$8.03M
Cap. Flow %
6.12%
Top 10 Hldgs %
94.91%
Holding
12
New
–
Increased
3
Reduced
1
Closed
–

Top Buys

1
VIRX
Viracta Therapeutics, Inc. Common Stock
VIRX
$6.08M
2
SYRE icon
Spyre Therapeutics
SYRE
$2.84M
3
TECX
Tectonic Therapeutic, Inc. Common Stock
TECX
$1.65M

Top Sells

1
RCUS icon
Arcus Biosciences
RCUS
$2.54M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
EIDX
1
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
$26.3M 20.07%
1,123,630
– –
TECX
2
Tectonic Therapeutic, Inc. Common Stock
TECX
$478M
$17.9M 13.64%
811,998
+75,000
+10% +$1.65M
OBSV
3
DELISTED
ObsEva SA Ordinary Shares
OBSV
$17.7M 13.51%
1,386,338
– –
BHVN
4
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$14.1M 10.76%
274,513
– –
MRKR icon
5
Marker Therapeutics
MRKR
$12M
$13.2M 10.06%
2,000,000
– –
SYRE icon
6
Spyre Therapeutics
SYRE
$996M
$9.83M 7.49%
1,220,911
+352,290
+41% +$2.84M
VIRX
7
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$9.23M 7.03%
7,600,000
+5,000,000
+192% +$6.08M
ZSAN
8
DELISTED
Zosano Pharma Corporation
ZSAN
$7.63M 5.81%
1,600,000
– –
NBRV
9
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$4.42M 3.36%
1,809,259
– –
RCUS icon
10
Arcus Biosciences
RCUS
$1.13B
$4.16M 3.17%
333,333
-203,180
-38% -$2.54M
ACRS icon
11
Aclaris Therapeutics
ACRS
$209M
$3.8M 2.89%
634,455
– –
VRNA
12
Verona Pharma
VRNA
$9.16B
$2.88M 2.2%
443,596
– –